Karen Anderson, Professor, Arizona State University, Mayo Clinic Arizona

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    pembrolizumab
    Date added:
    12/21/2023
    Date updated:
    12/21/2023
    Relationship end date:
    03/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Effector
    Topic:
    therapeutics
    Date added:
    12/21/2023
    Date updated:
    12/21/2023
    Relationship end date:
    12/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock Options
    Ineligible company:
    FlexBioTech
    Topic:
    molecular diagnostics
    Date added:
    12/21/2023
    Date updated:
    12/21/2023
Return to Southwest Hematology Oncology Conference: Precision Guided Therapy